Oxytocin release from the rat neurohypophysis into the blood: Effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists

Journal of Physiology and Pharmacology

Volumn 59, Issue 3, 2008, Pages 553-562

  Juszczak, Marlena ^a   Boczek Leszczyk, E ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NONE

Author keywords

Neurokinin A; Oxytocin; Substance P; Tachykinin receptors

Indexed keywords

NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR AGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A; OXYTOCIN; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HORMONE RESPONSE; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NEUROHYPOPHYSIS; NEUROTRANSMISSION; NONHUMAN; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; RAT;

ANALYSIS OF VARIANCE; ANIMALS; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROKININ A; OXYTOCIN; PEPTIDE FRAGMENTS; PITUITARY GLAND, POSTERIOR; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; SUBSTANCE P;

EID: 53649104789     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Buijs RM. Vasopressin and oxytocin - their role in neurotransmission. Pharmac Ther 1983; 22: 127-141.
2. Crowley WR, Armstrong WE. Neurochemical regulation of oxytocin secretion in lactation. Endocr Rev 1992; 13: 33-65.
3. Chowdrey HS, Lightman SL. Role of central amino acids and peptide-mediated pathways in neurohypophysial hormone release. Ann NY Acad Sci 1993; 689: 183-193.
4. Juszczak M, Steger RW, Fadden C, Bartke A. Oxytocin and prolactin release after hypertonic saline administration in melatonin-treated male Syrian hamsters. J Physiol Pharmacol 1996; 47: 289-301.
5. Juszczak M, Stempniak B. The effect of melatonin on suckling-induced oxytocin and prolactin release in the rat. Brain Res Bull 1997; 44: 253-258.
6. Juszczak M. Melatonin affects the oxytocin and prolactin responses to stress in male rats. J Physiol Pharmacol 1998; 49: 151-163.
7. Bojanowska E, Juszczak M, Guzek JW, Dabrowski R. Luteinizing hormone-releasing hormone and oxytocin response to hyperosmotic stimulation: in vitro study. Brain Res Bull 2000; 52: 303-307.
8. Lipinska S, Żebrowska-Badalla A, Lipińska J. Oxytocin release after bleeding in rat: the role of sympathetic and renin-angiotensin system. J Physiol Pharmacol 2006; 57: 627-636.
9. Sladek CD, Kapoor JR. Neurotransmitter/neuropeptides interactions in the regulation of neurohypophysial hormone release. Exp Neurology 2001; 171: 200-209.
10. Clarke G, Kirby PJC, Thomson AM. Effect on vasopressinergic and oxytocinergic neurones of intraventricular substance P. J Physiol (London) 1980; 307: 59P.
11. Kapoor JR, Sladek CD. Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release. Am J Physiol 2001; 280: R69-78.
12. Juszczak M. Neurokinin A and the neurohypophysial response to melatonin: in vitro studies. J Physiol Pharmacol 2002; 53: 823-834.
13. Juszczak M, Stempniak B. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamo-neurohypophysial system: in vitro studies. Brain Res Bull 2003; 59: 393-397.
14. Maggio J. Tachykinins. Ann Rev Neurosci 1988; 11: 13-28.
15. Harlan RE, Garcia MM, Krause JE. Cellular localization of substance P- and neurokinin A-encoding preprotachykinin mRNA in the female rat brain. J Comp Neurol 1989; 287: 179-212.
16. Nevin K, Zhuo H, Helke CJ. Neurokinin A coexists with substance P and serotonin in ventral medullary spinally projecting neurons of the rat. Peptides 1994; 15: 1003-1011.
17. Jessop DS, Chowdrey HS, Lightman SL. Substance P and substance K in the median eminence and paraventricular nucleus of the rat hypothalamus. Neuropeptides 1990; 17: 135-140.
18. Bittencourt JC, Benoit R, Sawchenko PE. Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: partial overlap with ascending catecholaminergic projections. J Chem Neuroanat 1991; 4: 63-78.
19. Mikkelsen JD, Larsen PJ, Moller M, Vilhardt H, Sarmark T. Substance P in the median eminence and pituitary of the rat: demonstration of immunoreactive fibres and specific binding sites. Neuroendocrinology 1989; 50: 100-108.
20. Mikkelsen JD, Schmidt P, Sheikh SP, Larsen PJ. Non-vasopressinergic, non-oxytocinergic neuropeptides in the rat hypothalamo-neurohypophyseal tract: experimental immunohistochemical studies. Prog Brain Res 1992; 91: 367-371.
21. Larsen PJ, Jessop DS, Chowdrey HS, Mikkelsen JD, Lightman SL. Osmotic regulation of substance P and neurokinin A peptide content and substance P binding sites in distinct hypothalamic nuclei of the rat. Peptides 1992; 13: 705-712.
22. Larsen PJ, Jessop DS, Lightman SL, Chowdrey HS. Preprotachykinin A gene expression in distinct hypothalamic and brain stem regions of the rat is affected by a chronic osmotic stimulus: a combined immunohistochemical and in situ hybridization histochemistry study. Brain Res Bull 1993; 30: 535-545.
23. Duval P, Lenoir V, Moussaoui S, Garret C, Kerdelhue B. Substance P and neurokinin A variations throughout the rat oestrous cycle; comparison with ovariectomized and male rats: I. Plasma, hypothalamus, anterior and posterior pituitary. J Neurosci Res 1996; 45: 598-609.
24. Liu HL, Cao R, Jin L, Chen LW. Immunocytochemical localization of substance P receptor in hypothalamic oxytocin-containing neurons of C57 mice. Brain Res 2002; 948: 175-179.
25. Chiodera P, Coiro V. Effects of intravenous infusion of substance P on arginine vasopressin and oxytocin secretion in normal men. Brain Research 1992; 569: 173-176.
26. De Laurentiis A, Pisera D, Duvilanski B, Rettori V, Lasaga M, Seilicovich A. Neurokinin A inhibits oxytocin and GABA release from the posterior pituitary by stimulating nitric oxide synthase. Brain Res Bull 2000; 53: 325-330.
27. Torrens Y, Beaujouan J-C, Dietl M, Saffroy M, Petitet F, Glowinski J. Tachykinin receptors: binding and cellular activity assays. Methods Neurosci 1991; 5: 243-267.
28. Juszczak M, Furykiewicz-Nykiś K, Stempniak B. Role of tachykinin receptors and melatonin in oxytocin secretion from isolated rat hypothalamo-neurohypophysial system. J Physiol Pharmacol 2004; 55: 739-749.
29. 3-norepinephrine into the lateral ventricle of the brain. Life Sci 1967; 6: 281-291.
30. Windle RJ, Forsling ML, Guzek JW. Daily rhythms in the hormone content of the neurohypophysial system and release of oxytocin and vasopressin in the male rat: effect of constant light. J Endocrinol 1992; 133: 283-290.
31. Guartara L, Maggi CA. The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides 1988; 32: 1-49.
32. Hagan RM, Beresford IJM, Stables J, et al. Characterization, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists. Reg Pept 1993; 46: 9-19.
33. Maeno H, Kiyama H, Tohyama M. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Mol Brain Res 1993; 18: 43-58.
34. Debeljuk L, Lasaga M. Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide γ. Peptides 1999; 20: 285-299.
35. Debeljuk L, Lasaga M. Tachykinins and the control of prolactin secretion. Peptides 2006; 27: 3007-3019.
36. Zubrzycka M, Janecka A. Effect of galanin on substance P and vasoactive intestinal polypeptide-induced nociceptive trigemino-hypoglossal reflex in rats. J Physiol Pharmacol 2007; 58: 479-486.
37. Sakurada T, Manome Y, Tan-No K, et al. A selective and extremely potent antagonist of the neurokinin-1 receptor. Brain Res 1992; 593: 319-322.
38. Baruch P, Artaud F, Godeheu G, Barbeito L, Glowinski J, Cheramy A. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrities and nerve terminals of the nigrostriatal dopaminergic neurons. Neuroscience 1988; 25: 889-898.